International Journal of Scientific Research and Engineering Development

Pilocarpine Ocusert is a controlled-release ocular implant used to treat glaucoma by directly delivering the muscarinic agonist pilocarpine to the eye. By delivering pilocarpine in a continuous release, this novel delivery method lowers intraocular pressure (IOP) and enhances therapeutic results. The benefits of the Ocusert include increased efficacy, decreased systemic adverse effects, and better patient compliance. The Ocusert slows the growth of glaucoma and preserves eyesight by ensuring a steady delivery of medication. The need for patient education and encouragement, retention issues (some patients were unaware when the device was lost), sporadic side effects like a cutting sensation (the Ocusert occasionally doubles over), eye movement, temporary blurring of vision, and miosis, and high cost were some of the drawbacks. All things considered, the Ocusert pilocarpine system has several clear benefits over pilocarpine eyedrops and is a very popular therapeutic approach for some glaucoma cases.